Presentation is loading. Please wait.

Presentation is loading. Please wait.

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Neal I. Lindeman, Philip T. Cagle, Mary Beth.

Similar presentations


Presentation on theme: "Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Neal I. Lindeman, Philip T. Cagle, Mary Beth."— Presentation transcript:

1 Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Neal I. Lindeman, Philip T. Cagle, Mary Beth Beasley, Dhananjay Arun Chitale, Sanja Dacic, Giuseppe Giaccone, Robert Brian Jenkins, David J. Kwiatkowski, Juan-Sebastian Saldivar, Jeremy Squire, Erik Thunnissen, Marc Ladanyi The Journal of Molecular Diagnostics Volume 15, Issue 4, Pages 415-453 (July 2013) DOI: 10.1016/j.jmoldx.2013.03.001 Copyright © 2013 College of American Pathologists, American Society for Investigative Pathology, Association for Molecular Pathology, and the International Association for the Study of Lung Cancer Terms and Conditions Terms and Conditions

2 Figure 1 The Journal of Molecular Diagnostics 2013 15, 415-453DOI: (10.1016/j.jmoldx.2013.03.001) Copyright © 2013 College of American Pathologists, American Society for Investigative Pathology, Association for Molecular Pathology, and the International Association for the Study of Lung Cancer Terms and Conditions Terms and Conditions

3 Figure 2 The Journal of Molecular Diagnostics 2013 15, 415-453DOI: (10.1016/j.jmoldx.2013.03.001) Copyright © 2013 College of American Pathologists, American Society for Investigative Pathology, Association for Molecular Pathology, and the International Association for the Study of Lung Cancer Terms and Conditions Terms and Conditions

4 Figure 3 The Journal of Molecular Diagnostics 2013 15, 415-453DOI: (10.1016/j.jmoldx.2013.03.001) Copyright © 2013 College of American Pathologists, American Society for Investigative Pathology, Association for Molecular Pathology, and the International Association for the Study of Lung Cancer Terms and Conditions Terms and Conditions

5 Figure 4 The Journal of Molecular Diagnostics 2013 15, 415-453DOI: (10.1016/j.jmoldx.2013.03.001) Copyright © 2013 College of American Pathologists, American Society for Investigative Pathology, Association for Molecular Pathology, and the International Association for the Study of Lung Cancer Terms and Conditions Terms and Conditions


Download ppt "Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Neal I. Lindeman, Philip T. Cagle, Mary Beth."

Similar presentations


Ads by Google